Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Chapter 1 - Cardiac Complications of Cancer and Anti-Cancer Treatment

Chapter 1 - Cardiac complications of cancer and anti-cancer treatment

Neoplastic diseases can be associated with severe, sometimes fatal, cardiac complications such as pericardial effusion and cardiac tamponade. In addition, several anti-cancer agents can induce potentially irreversible cardiac dysfunction, and the development of targeted therapies has recently widened the cardiotoxic spectrum of antineoplastic drugs.

Increasing the chance of survival as a consequence of improvements in cancer diagnosis and treatment highlights the relevance of this topic, since cardiac complications can adversely affect survival and quality of life independently of cancer prognosis. In this chapter, we briefly review the cardiac complications of both neoplastic diseases and cancer treatments, describing their incidence and aetiology, and focusing on strategies to evaluate, treat and prevent this wide spectrum of disorders.

Malignant Pericardial Effusion and Cardiac Tamponade

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings